GeoVax

Results: 20



#Item
1April 2, 2015 Dear Fellow Shareholders: It is a pleasure to provide you with an update on GeoVax’s corporate and clinical progress during 2014, and to provide some insight as to what you should expect during 2015 and b

April 2, 2015 Dear Fellow Shareholders: It is a pleasure to provide you with an update on GeoVax’s corporate and clinical progress during 2014, and to provide some insight as to what you should expect during 2015 and b

Add to Reading List

Source URL: www.geovax.com

Language: English - Date: 2015-04-06 09:28:05
    2April 2, 2015 Dear Fellow Shareholders: It is a pleasure to provide you with an update on GeoVax’s corporate and clinical progress during 2014, and to provide some insight as to what you should expect during 2015 and b

    April 2, 2015 Dear Fellow Shareholders: It is a pleasure to provide you with an update on GeoVax’s corporate and clinical progress during 2014, and to provide some insight as to what you should expect during 2015 and b

    Add to Reading List

    Source URL: geovax.com

    Language: English - Date: 2015-04-06 09:28:05
      3Interim Financial Report for the Period January 1 to March 31, 2015

      Interim Financial Report for the Period January 1 to March 31, 2015

      Add to Reading List

      Source URL: www.bavarian-nordic.com

      Language: English - Date: 2015-05-05 01:45:46
      4a Publication of the HIV Vaccine Trials Network Volume 4, issue 2 | FEBRUARY, 2013 CLOSING IN ON

      a Publication of the HIV Vaccine Trials Network Volume 4, issue 2 | FEBRUARY, 2013 CLOSING IN ON

      Add to Reading List

      Source URL: www.hvtn.org

      Language: English - Date: 2014-04-02 14:04:43
      5HVTN Ongoing Protocols Protocol Product Developer /

      HVTN Ongoing Protocols Protocol Product Developer /

      Add to Reading List

      Source URL: www.hvtn.org

      Language: English - Date: 2014-04-30 19:08:38
      6Office of the Gene Technology Regulator April 2014 Questions & Answers on licence application DIR 126 – Clinical trial of a genetically modified (GM) vaccine against cholera

      Office of the Gene Technology Regulator April 2014 Questions & Answers on licence application DIR 126 – Clinical trial of a genetically modified (GM) vaccine against cholera

      Add to Reading List

      Source URL: www.ogtr.gov.au

      Language: English - Date: 2015-03-06 01:38:31
      708. Jan Langermans pdf version [Compatibility Mode]

      08. Jan Langermans pdf version [Compatibility Mode]

      Add to Reading List

      Source URL: www.eatris.eu

      Language: English - Date: 2014-10-24 02:03:46
      8Updated english press release

      Updated english press release

      Add to Reading List

      Source URL: hugin.info

      Language: English - Date: 2007-11-09 04:04:41
      9Medical Officer, CTC, VRC, NIAID

      Medical Officer, CTC, VRC, NIAID

      Add to Reading List

      Source URL: www.niaid.nih.gov

      Language: English - Date: 2014-12-31 09:01:36
      10RAC Meeting Minutes - Dec 13-14, 2011

      RAC Meeting Minutes - Dec 13-14, 2011

      Add to Reading List

      Source URL: osp.od.nih.gov

      Language: English - Date: 2013-11-26 15:22:15